Roper Technologies (NASDAQ: ROP) — 2Q26 Earnings Preview

Timing note: Roper is scheduled to report before the market opens today, Thursday, July 23, 2026, followed by an 8:00 a.m. ET earnings call. The event is therefore today—not tomorrow.

Investment framing

Roper enters 2Q26 with a relatively straightforward setup: management has already signaled a temporarily softer organic-growth quarter, principally due to application-software nonrecurring-revenue timing and a difficult Technology Enabled Products (TEP) comparison. The key question is whether that anticipated softness is simply calendar/comparison-driven—as management maintained in April—or whether it reflects any deterioration in the company’s otherwise solid software demand indicators.

The bull case remains centered on Roper’s highly recurring vertical-software portfolio, strong retention and bookings, a multi-year cloud-migration opportunity, expanding AI product commercialization, and substantial capital-allocation flexibility. The bear case is that investors may be unwilling to look through a growth deceleration if Deltek’s government-contractor market, DAT’s freight exposure, or Neptune’s water-meter business worsens further—or if management does not again raise full-year expectations after a strong first quarter.

At $336.75 on July 22, ROP had fallen about 7.2% in the prior two trading sessions and 7.7% since April 22. On the midpoint of its current adjusted-DEPS guide, the stock trades at roughly 15.4x 2026 adjusted EPS.


The headline setup: guidance is the primary benchmark

For 2Q26, Roper guided to:

Metric 2Q26 guidance / reference point
Adjusted diluted EPS $5.25–$5.30
Full-year 2026 adjusted diluted EPS $21.80–$22.05
Full-year revenue growth ~8%
Full-year organic revenue growth 5%–6%
Tax rate Around 21% for FY26; modestly below that in 2Q
Assumed macro recovery None at Deltek GovCon, DAT freight, or Neptune

The company raised its full-year adjusted EPS outlook by $0.50 at the midpoint after 1Q26, but that increase largely reflected the first-quarter beat and already executed share repurchases rather than a higher core revenue or EBITDA outlook. That distinction matters: investors will likely want evidence that the organic-growth and margin trajectory supports another increase rather than merely EPS accretion from a smaller share count.

Prior-year comparison

2Q25 set a high bar in underlying operating performance:

2Q25 actual Result
Revenue $1.94 billion
Organic revenue growth +7%
Adjusted EBITDA $775 million
Adjusted EBITDA margin 39.9%
Adjusted EPS $4.87
Adjusted free cash flow $403 million

Management specifically described 2Q26 as a lower-growth quarter, so a year-over-year organic deceleration should not itself be surprising. The more important issue is whether results remain consistent with the company’s 5%–6% full-year organic-growth framework and whether the expected second-half acceleration remains credible.


What investors should watch

1. Organic growth: quality and composition matter more than the headline

Roper delivered 6% organic growth in 1Q26, ahead of its full-year 5%–6% framework. Management then warned that 2Q would be lower, driven by:

A clean quarter would show that recurring software revenue, retention, bookings, and cloud conversions remain intact even if reported organic growth moderates. A more concerning result would be broad-based weakness in recurring revenue or bookings, which would call into question the second-half recovery embedded in the annual outlook.

Key operating indicators

Investors should focus on:


2. Application Software: strongest long-term asset, but a near-term timing headwind

Application Software is the largest and most important segment. In 1Q26, it produced 5% organic growth, with recurring/reoccurring revenue—about 85% of segment revenue—growing mid-single digits or better. Management expected 2Q growth to be lower because of nonrecurring-revenue timing, followed by improvement in the back half.

What should matter on the call

Read-through: A stable Deltek update is probably sufficient. An actual GovCon recovery would be upside, but investors should not expect it to be necessary for guidance maintenance.


3. Network Software: DAT and freight are the largest debate

Network Software grew 5% organically in 1Q26, supported by construction and healthcare-oriented businesses, but its margin profile was diluted by the lower-margin Subsplash acquisition and continuing investment in Convoy within DAT.

DAT: watch for confirmation, not a recovery call

Management cited encouraging freight-market data in 1Q:

That makes DAT a potential upside lever if market conditions improve. But the company’s credibility depends on maintaining discipline: investors are likely to favor an unchanged conservative macro stance over a premature recovery narrative.

The strategic opportunity is Convoy: Roper is attempting to move DAT from a subscription-based freight-information network toward a more automated transaction marketplace. This is a meaningful TAM expansion opportunity, but it remains an investment that pressures Network Software margins today.

Other areas to monitor


4. TEP: growth is less durable and margins are under pressure

TEP surprised positively in 1Q with 7% organic growth, led by NDI and Verathon. But management cautioned that 2Q should be lower because of a tough comparison and ongoing raw-material pressure.

Key crosscurrents

Positive - NDI continues to benefit from demand for electromagnetic tracking in cardiac, neurological, and orthopedic procedures. - Verathon has seen healthy demand for airway-management products and expects additional product launches during the year. - Faster-growing consumables improve revenue durability.

Negative - The consumables mix carries lower gross margins. - Neptune faces weaker mechanical-meter demand and elevated bronze-ingot costs. - Roper expects raw-material pressure to persist through 2Q and improve in the back half.

Neptune is particularly important for margin expectations. Management has not underwritten a 2026 demand recovery and has said pricing actions will take time to work through backlog. A better-than-feared Neptune result would help sentiment, but it is not required for the annual plan.


5. AI: investors need tangible commercialization evidence

AI is now central to the Roper narrative, but the earnings call needs to distinguish product activity from revenue impact.

The company has meaningful examples of productivity and workflow value:

The key question is whether Roper can commercialize these products without structurally increasing its cost base or compressing margins. Management’s stated model is generally subscription pricing with potential usage-based overages, rather than pure per-token or per-click pricing. Investors should listen for:

  1. Incremental AI ARR or bookings, rather than qualitative adoption alone.
  2. Pricing and packaging progress.
  3. Evidence that deployment requirements are manageable.
  4. Margin implications of AI compute, engineering, and customer-success investment.
  5. Whether AI helps accelerate cloud conversion and cross-sell.

Capital allocation: a material EPS and strategic lever

Roper deployed heavily into buybacks early in 2026:

This activity supports per-share earnings and cash-flow growth, but it also increased leverage: net debt to EBITDA was 3.1x at the end of 1Q, compared with 2.9x at year-end. Roper still has substantial liquidity and described more than $5 billion of annualized capital-deployment capacity, but investors will want management to address the balance between:


Earnings-call questions that matter

  1. Does full-year organic-growth guidance remain 5%–6%, and what specifically supports the expected second-half acceleration?
  2. Was the 2Q slowdown entirely attributable to the previously flagged application-software timing and TEP comparison?
  3. How did recurring revenue, bookings, and gross retention trend relative to 1Q?
  4. Is Deltek seeing any tangible normalization in GovCon enterprise decision-making?
  5. What is the latest on DAT carrier activity, pricing, and Convoy monetization?
  6. Has Neptune demand or raw-material inflation changed relative to the April outlook?
  7. What measurable AI commercialization milestones can management provide—ARR, bookings, pricing, or customer deployment data?
  8. How much incremental buyback is embedded in current EPS guidance, if any?
  9. Has the M&A pipeline reopened, and is Roper seeing valuation opportunities that compete favorably with repurchases?

Bottom line

The most likely constructive outcome is not necessarily a large 2Q headline beat. It is a quarter that confirms the company’s expected near-term organic-growth softness is mechanical rather than demand-driven, preserves the 5%–6% full-year organic-growth outlook, and provides confidence in second-half contributions from CentralReach, Subsplash, cloud conversion, and easier comparisons.

For the shares, the hierarchy of importance is likely:

  1. Full-year organic-growth and EPS outlook
  2. Recurring revenue, bookings, and retention
  3. Deltek / DAT / Neptune commentary
  4. Software and TEP margin trajectory
  5. Evidence of AI monetization
  6. Capital allocation: buybacks versus M&A

A maintained or raised outlook accompanied by durable software KPIs should be enough to support the stock after its recent pullback. Conversely, a guide cut—or evidence that weakness has broadened beyond the pre-announced 2Q timing effects—would likely outweigh an EPS beat.